Lyra Therapeutics (LYRA) Non-Current Assets (2019 - 2025)
Quarterly Non-Current Assets fell 14.94% to $19.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $84.4 million through Dec 2025, down 32.37% year-over-year, with the annual reading at $19.8 million for FY2025, 14.94% down from the prior year.
Lyra Therapeutics' Non-Current Assets history spans 7 years, with the latest figure at $19.8 million for Q4 2025.
- Non-Current Assets came in at $19.8 million for Q4 2025, down from $20.7 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $52.1 million in Q1 2024 to a low of $5.6 million in Q1 2021.
- The 5-year median for Non-Current Assets is $12.4 million (2022), against an average of $16.8 million.
- Year-over-year, Non-Current Assets skyrocketed 474.31% in 2024 and then tumbled 56.97% in 2025.
- Lyra Therapeutics' Non-Current Assets stood at $6.9 million in 2021, then surged by 31.52% to $9.1 million in 2022, then skyrocketed by 313.38% to $37.8 million in 2023, then plummeted by 38.27% to $23.3 million in 2024, then fell by 14.94% to $19.8 million in 2025.
- Per Business Quant, the three most recent readings for LYRA's Non-Current Assets are $19.8 million (Q4 2025), $20.7 million (Q3 2025), and $21.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 4.56 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 62,953.78 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 486.60 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 5.83 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.75 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 22.66 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 910.24 Mn |
| 10 | Lyra Therapeutics | - | - | - | 19.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.84 Mn |
| Sep 30, 2025 | 20.69 Mn |
| Jun 30, 2025 | 21.51 Mn |
| Mar 31, 2025 | 22.41 Mn |
| Dec 31, 2024 | 23.32 Mn |
| Sep 30, 2024 | 24.31 Mn |
| Jun 30, 2024 | 25.15 Mn |
| Mar 31, 2024 | 52.08 Mn |
| Dec 31, 2023 | 37.78 Mn |
| Sep 30, 2023 | 15.66 Mn |
| Jun 30, 2023 | 7.42 Mn |
| Mar 31, 2023 | 9.07 Mn |
| Dec 31, 2022 | 9.14 Mn |
| Sep 30, 2022 | 7.23 Mn |
| Jun 30, 2022 | 7.65 Mn |
| Mar 31, 2022 | 6.79 Mn |
| Dec 31, 2021 | 6.95 Mn |
| Sep 30, 2021 | 6.88 Mn |
| Jun 30, 2021 | 6.26 Mn |
| Mar 31, 2021 | 5.57 Mn |
| Dec 31, 2020 | 4.91 Mn |
| Sep 30, 2020 | 3.78 Mn |
| Jun 30, 2020 | 3.41 Mn |
| Mar 31, 2020 | 5.23 Mn |
| Dec 31, 2019 | 4.84 Mn |